GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company's primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates... GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company's primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee. Show more
GoodRx Holdings, Inc. (Nasdaq: GDRX) (โGoodRxโ or the โCompanyโ), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.97 | -12.5974025974 | 7.7 | 7.8 | 6.71 | 1091538 | 7.09420059 | CS |
4 | -1.3 | -16.1892901619 | 8.03 | 8.8 | 6.71 | 1133126 | 7.7601381 | CS |
12 | -1.03 | -13.2731958763 | 7.76 | 9.2599 | 6.25 | 1382483 | 7.86157876 | CS |
26 | -0.87 | -11.4473684211 | 7.6 | 9.2599 | 6.25 | 1323091 | 7.65251034 | CS |
52 | 1.23 | 22.3636363636 | 5.5 | 9.2599 | 4.135 | 1438658 | 6.83885472 | CS |
156 | -39.53 | -85.4517942067 | 46.26 | 47.535 | 3.8201 | 1871376 | 10.89796909 | CS |
260 | -42.39 | -86.2988599349 | 49.12 | 64.2185 | 3.8201 | 1968964 | 19.56167731 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.